170 related articles for article (PubMed ID: 7146043)
1. Dopaminergic activity of quipazine.
Schechter MD; Concannon JT
Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
[TBL] [Abstract][Full Text] [Related]
2. Possible dopamine agonist properties of quipazine maleate.
Feigenbaum JJ; Yanai J; Klawans HL
Int J Neurosci; 1983; 18(3-4):205-10. PubMed ID: 6222999
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol-induced supersensitivity to the discrimination of apomorphine.
Schechter MD
Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
5. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
Feigenbaum JJ; Yanai J; Klawans HL
J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
[TBL] [Abstract][Full Text] [Related]
6. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Langlais PJ; Gabay S
J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
[TBL] [Abstract][Full Text] [Related]
7. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
Dall'Olio R; Vaccheri A; Montanaro N
Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
Callahan PM; Appel JB
Psychopharmacology (Berl); 1990; 100(1):13-8. PubMed ID: 2296621
[TBL] [Abstract][Full Text] [Related]
9. Apomorphine increases ethanol discrimination.
Schechter MD
Pharmacol Biochem Behav; 1985 Feb; 22(2):179-82. PubMed ID: 3983211
[TBL] [Abstract][Full Text] [Related]
10. The combined effect of quipazine and haloperidol on plasma prolactin release.
Feigenbaum J; Yanai J; Klawans HL; Chatterton R
Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
[TBL] [Abstract][Full Text] [Related]
11. Is there a "serotonergic syndrome" in neonatal rat pups?
Ristine LA; Spear LP
Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
[TBL] [Abstract][Full Text] [Related]
12. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
[TBL] [Abstract][Full Text] [Related]
13. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.
Balsara JJ; Jadhav JH; Chandorkar AG
Psychopharmacology (Berl); 1979 Mar; 62(1):67-9. PubMed ID: 108749
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline.
Woolverton WL; Kamien JB; Goldberg LI
Pharmacol Biochem Behav; 1985 Apr; 22(4):577-81. PubMed ID: 3873077
[TBL] [Abstract][Full Text] [Related]
15. Effects of quipazine and methysergide on play in juvenile rats.
Normansell L; Panksepp J
Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of noradrenaline in some effects of quipazine.
Francès H; Lecrubier Y; Puech AJ; Simon P
Psychopharmacology (Berl); 1980; 67(3):307-10. PubMed ID: 6770410
[TBL] [Abstract][Full Text] [Related]
17. Caffeine potentiation of apomorphine discrimination.
Schechter MD
Pharmacol Biochem Behav; 1980 Aug; 13(2):307-9. PubMed ID: 6251484
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in the sensitivity of cholinergic neurons to dopaminergic drugs and quipazine in the rat striatum.
Guyenet P; Euvrard C; Javoy F; Herbert A; Glowinski J
Brain Res; 1977 Nov; 136(3):487-500. PubMed ID: 922497
[TBL] [Abstract][Full Text] [Related]
19. Methysergide blocks the sleep suppressant action of quipazine in rats.
Fornal C; Radulovacki M
Psychopharmacology (Berl); 1982; 76(3):255-9. PubMed ID: 6808546
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
